The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance
Identifieur interne : 001125 ( Istex/Corpus ); précédent : 001124; suivant : 001126The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance
Auteurs : N. Moore ; D. Montero ; R. Coulson ; F. De Abajo ; C. Kreft-Jais ; A. Biron ; J. L. MonteagudoSource :
- Pharmacoepidemiology and Drug Safety [ 1053-8569 ] ; 1994-05.
English descriptors
- KwdEn :
Abstract
The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.
Url:
DOI: 10.1002/pds.2630030306
Links to Exploration step
ISTEX:758673941CD84142C36F044BDAB0D41FAAA4A937Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title><author><name sortKey="Moore, N" sort="Moore, N" uniqKey="Moore N" first="N." last="Moore">N. Moore</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Montero, D" sort="Montero, D" uniqKey="Montero D" first="D." last="Montero">D. Montero</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author><author><name sortKey="Coulson, R" sort="Coulson, R" uniqKey="Coulson R" first="R." last="Coulson">R. Coulson</name><affiliation><mods:affiliation>Medicines Control Agency, London, UK</mods:affiliation></affiliation></author><author><name sortKey="De Abajo, F" sort="De Abajo, F" uniqKey="De Abajo F" first="F." last="De Abajo">F. De Abajo</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author><author><name sortKey="Kreft Ais, C" sort="Kreft Ais, C" uniqKey="Kreft Ais C" first="C." last="Kreft-Jais">C. Kreft-Jais</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Biron, A" sort="Biron, A" uniqKey="Biron A" first="A." last="Biron">A. Biron</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Monteagudo, J L" sort="Monteagudo, J L" uniqKey="Monteagudo J" first="J. L." last="Monteagudo">J. L. Monteagudo</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:758673941CD84142C36F044BDAB0D41FAAA4A937</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1002/pds.2630030306</idno><idno type="url">https://api.istex.fr/document/758673941CD84142C36F044BDAB0D41FAAA4A937/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001125</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001125</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title><author><name sortKey="Moore, N" sort="Moore, N" uniqKey="Moore N" first="N." last="Moore">N. Moore</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Montero, D" sort="Montero, D" uniqKey="Montero D" first="D." last="Montero">D. Montero</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author><author><name sortKey="Coulson, R" sort="Coulson, R" uniqKey="Coulson R" first="R." last="Coulson">R. Coulson</name><affiliation><mods:affiliation>Medicines Control Agency, London, UK</mods:affiliation></affiliation></author><author><name sortKey="De Abajo, F" sort="De Abajo, F" uniqKey="De Abajo F" first="F." last="De Abajo">F. De Abajo</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author><author><name sortKey="Kreft Ais, C" sort="Kreft Ais, C" uniqKey="Kreft Ais C" first="C." last="Kreft-Jais">C. Kreft-Jais</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Biron, A" sort="Biron, A" uniqKey="Biron A" first="A." last="Biron">A. Biron</name><affiliation><mods:affiliation>French Pharmacovigilance System, Agence du Médicament, France</mods:affiliation></affiliation></author><author><name sortKey="Monteagudo, J L" sort="Monteagudo, J L" uniqKey="Monteagudo J" first="J. L." last="Monteagudo">J. L. Monteagudo</name><affiliation><mods:affiliation>Instituto de Salud Carlos III, Madrid, Spain</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Pharmacoepidemiology and Drug Safety</title><title level="j" type="abbrev">Pharmacoepidem. Drug Safe.</title><idno type="ISSN">1053-8569</idno><idno type="eISSN">1099-1557</idno><imprint><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester</pubPlace><date type="published" when="1994-05">1994-05</date><biblScope unit="volume">3</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="157">157</biblScope><biblScope unit="page" to="162">162</biblScope></imprint><idno type="ISSN">1053-8569</idno></series><idno type="istex">758673941CD84142C36F044BDAB0D41FAAA4A937</idno><idno type="DOI">10.1002/pds.2630030306</idno><idno type="ArticleID">PDS2630030306</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1053-8569</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Europe</term><term>Pharmacovigilance</term><term>adverse reactions</term><term>electronic data interchange</term><term>regulations</term><term>reports</term><term>telematics</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>N. Moore</name><affiliations><json:string>French Pharmacovigilance System, Agence du Médicament, France</json:string></affiliations></json:item><json:item><name>D. Montero</name><affiliations><json:string>Instituto de Salud Carlos III, Madrid, Spain</json:string></affiliations></json:item><json:item><name>R. Coulson</name><affiliations><json:string>Medicines Control Agency, London, UK</json:string></affiliations></json:item><json:item><name>F. De Abajo</name><affiliations><json:string>Instituto de Salud Carlos III, Madrid, Spain</json:string></affiliations></json:item><json:item><name>C. Kreft‐Jais</name><affiliations><json:string>French Pharmacovigilance System, Agence du Médicament, France</json:string></affiliations></json:item><json:item><name>A. Biron</name><affiliations><json:string>French Pharmacovigilance System, Agence du Médicament, France</json:string></affiliations></json:item><json:item><name>J. L. Monteagudo</name><affiliations><json:string>Instituto de Salud Carlos III, Madrid, Spain</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Pharmacovigilance</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>telematics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>adverse reactions</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>reports</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>electronic data interchange</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>regulations</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Europe</value></json:item></subject><articleId><json:string>PDS2630030306</json:string></articleId><language><json:string>eng</json:string></language><abstract>The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.</abstract><qualityIndicators><score>3.731</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 720 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>7</keywordCount><abstractCharCount>804</abstractCharCount><pdfWordCount>2303</pdfWordCount><pdfCharCount>15317</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>119</abstractWordCount></qualityIndicators><title>The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title><genre.original><json:string>miscellaneous</json:string></genre.original><genre><json:string>other</json:string></genre><host><volume>3</volume><publisherId><json:string>PDS</json:string></publisherId><pages><total>6</total><last>162</last><first>157</first></pages><issn><json:string>1053-8569</json:string></issn><issue>3</issue><subject><json:item><value>Special Report</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1099-1557</json:string></eissn><title>Pharmacoepidemiology and Drug Safety</title><doi><json:string>10.1002/(ISSN)1099-1557</json:string></doi></host><publicationDate>1994</publicationDate><copyrightDate>1994</copyrightDate><doi><json:string>10.1002/pds.2630030306</json:string></doi><id>758673941CD84142C36F044BDAB0D41FAAA4A937</id><score>1</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/758673941CD84142C36F044BDAB0D41FAAA4A937/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/758673941CD84142C36F044BDAB0D41FAAA4A937/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/758673941CD84142C36F044BDAB0D41FAAA4A937/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester</pubPlace><availability><p>WILEY</p></availability><date>1994</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title><author><persName><forename type="first">N.</forename><surname>Moore</surname></persName><note type="correspondence"><p>Correspondence: CHU de Rouen, 76031 Rouen Cedex, France</p></note><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation></author><author><persName><forename type="first">D.</forename><surname>Montero</surname></persName><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation></author><author><persName><forename type="first">R.</forename><surname>Coulson</surname></persName><affiliation>Medicines Control Agency, London, UK</affiliation></author><author><persName><forename type="first">F.</forename><surname>De Abajo</surname></persName><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation></author><author><persName><forename type="first">C.</forename><surname>Kreft‐Jais</surname></persName><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation></author><author><persName><forename type="first">A.</forename><surname>Biron</surname></persName><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation></author><author><persName><forename type="first">J. L.</forename><surname>Monteagudo</surname></persName><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation></author></analytic><monogr><title level="j">Pharmacoepidemiology and Drug Safety</title><title level="j" type="abbrev">Pharmacoepidem. Drug Safe.</title><idno type="pISSN">1053-8569</idno><idno type="eISSN">1099-1557</idno><idno type="DOI">10.1002/(ISSN)1099-1557</idno><imprint><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester</pubPlace><date type="published" when="1994-05"></date><biblScope unit="volume">3</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="157">157</biblScope><biblScope unit="page" to="162">162</biblScope></imprint></monogr><idno type="istex">758673941CD84142C36F044BDAB0D41FAAA4A937</idno><idno type="DOI">10.1002/pds.2630030306</idno><idno type="ArticleID">PDS2630030306</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1994</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>Pharmacovigilance</term></item><item><term>telematics</term></item><item><term>adverse reactions</term></item><item><term>reports</term></item><item><term>electronic data interchange</term></item><item><term>regulations</term></item><item><term>Europe</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Special Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1994-03-31">Received</change><change when="1994-05-19">Registration</change><change when="1994-05">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/758673941CD84142C36F044BDAB0D41FAAA4A937/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd.</publisherName><publisherLoc>Chichester</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1099-1557</doi><issn type="print">1053-8569</issn><issn type="electronic">1099-1557</issn><idGroup><id type="product" value="PDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="PHARMACOEPIDEMIOLOGY AND DRUG SAFETY">Pharmacoepidemiology and Drug Safety</title><title type="short">Pharmacoepidem. Drug Safe.</title></titleGroup></publicationMeta><publicationMeta level="part" position="30"><doi origin="wiley" registered="yes">10.1002/pds.v3:3</doi><numberingGroup><numbering type="journalVolume" number="3">3</numbering><numbering type="journalIssue">3</numbering></numberingGroup><coverDate startDate="1994-05">May/June 1994</coverDate></publicationMeta><publicationMeta level="unit" type="miscellaneous" position="6" status="forIssue"><doi origin="wiley" registered="yes">10.1002/pds.2630030306</doi><idGroup><id type="unit" value="PDS2630030306"></id></idGroup><countGroup><count type="pageTotal" number="6"></count></countGroup><titleGroup><title type="articleCategory">Special Report</title><title type="tocHeading1">Special Report</title></titleGroup><copyright ownership="publisher">Copyright © 1994 John Wiley & Sons, Ltd.</copyright><eventGroup><event type="manuscriptReceived" date="1994-03-31"></event><event type="manuscriptAccepted" date="1994-05-19"></event><event type="firstOnline" date="2006-01-12"></event><event type="publishedOnlineFinalForm" date="2006-01-12"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-02"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-06"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst">157</numbering><numbering type="pageLast">162</numbering></numberingGroup><correspondenceTo>CHU de Rouen, 76031 Rouen Cedex, France</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:PDS.PDS2630030306.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="5"></count></countGroup><titleGroup><title type="main" xml:lang="en">The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title><title type="short" xml:lang="en">THE SINGLE CASE FORMAT</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>N.</givenNames><familyName>Moore</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>D.</givenNames><familyName>Montero</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>R.</givenNames><familyName>Coulson</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>F.</givenNames><familyName>De Abajo</familyName></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>C.</givenNames><familyName>Kreft‐Jais</familyName></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>A.</givenNames><familyName>Biron</familyName></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af2"><personName><givenNames>J. L.</givenNames><familyName>Monteagudo</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="FR" type="organization"><unparsedAffiliation>French Pharmacovigilance System, Agence du Médicament, France</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="ES" type="organization"><unparsedAffiliation>Instituto de Salud Carlos III, Madrid, Spain</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="GB" type="organization"><unparsedAffiliation>Medicines Control Agency, London, UK</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Pharmacovigilance</keyword><keyword xml:id="kwd2">telematics</keyword><keyword xml:id="kwd3">adverse reactions</keyword><keyword xml:id="kwd4">reports</keyword><keyword xml:id="kwd5">electronic data interchange</keyword><keyword xml:id="kwd6">regulations</keyword><keyword xml:id="kwd7">Europe</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>THE SINGLE CASE FORMAT</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance</title></titleInfo><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Moore</namePart><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation><description>Correspondence: CHU de Rouen, 76031 Rouen Cedex, France</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Montero</namePart><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Coulson</namePart><affiliation>Medicines Control Agency, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">De Abajo</namePart><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Kreft‐Jais</namePart><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Biron</namePart><affiliation>French Pharmacovigilance System, Agence du Médicament, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J. L.</namePart><namePart type="family">Monteagudo</namePart><affiliation>Instituto de Salud Carlos III, Madrid, Spain</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="miscellaneous"></genre><originInfo><publisher>John Wiley & Sons, Ltd.</publisher><place><placeTerm type="text">Chichester</placeTerm></place><dateIssued encoding="w3cdtf">1994-05</dateIssued><dateCaptured encoding="w3cdtf">1994-03-31</dateCaptured><dateValid encoding="w3cdtf">1994-05-19</dateValid><copyrightDate encoding="w3cdtf">1994</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="references">5</extent></physicalDescription><abstract lang="en">The development of telematic exchange of information in pharmacovigilance has as a consequence the necessary development of the messages used to transmit the information. The first of these messages is the one used to transmit information on individual case reports. Common formats exist on paper, but these have not been applied to electronic transmission. A structured message for the transmission of single case information has been developed within the ENS European research programme, by three National Pharmacovigilance administrations, and reviewed by the relevant European bodies. It has been submitted to the Western European Edifact Board MD9 for admission as an EDIFACT message, so that it will be possible to exchange information concerning these single cases, using standard EDI methodology.</abstract><subject lang="en"><genre>keywords</genre><topic>Pharmacovigilance</topic><topic>telematics</topic><topic>adverse reactions</topic><topic>reports</topic><topic>electronic data interchange</topic><topic>regulations</topic><topic>Europe</topic></subject><relatedItem type="host"><titleInfo><title>Pharmacoepidemiology and Drug Safety</title></titleInfo><titleInfo type="abbreviated"><title>Pharmacoepidem. Drug Safe.</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Special Report</topic></subject><identifier type="ISSN">1053-8569</identifier><identifier type="eISSN">1099-1557</identifier><identifier type="DOI">10.1002/(ISSN)1099-1557</identifier><identifier type="PublisherID">PDS</identifier><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>157</start><end>162</end><total>6</total></extent></part></relatedItem><identifier type="istex">758673941CD84142C36F044BDAB0D41FAAA4A937</identifier><identifier type="DOI">10.1002/pds.2630030306</identifier><identifier type="ArticleID">PDS2630030306</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1994 John Wiley & Sons, Ltd.</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>John Wiley & Sons, Ltd.</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001125 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001125 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= TelematiV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:758673941CD84142C36F044BDAB0D41FAAA4A937
|texte= The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance
}}
| This area was generated with Dilib version V0.6.31. |  |